ArticleRespiratory research2026
Blood viscosity is associated with smoking status rather than the presence of chronic obstructive pulmonary disease: findings from the Korea COPD Subgroup Study (KOCOSS).
Article in Respiratory research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundThe relationship between smoking and blood viscosity is well established. However, the role of blood viscosity in the development of chronic obstructive pulmonary disease (COPD) and its impact on lung function decline remains unclear. Therefore, we aimed to investigate the association of blood viscosity with COPD and lung function decline, independent of smoking status.
methodsData from 292 participants in the Korea COPD Subgroup Study (KOCOSS), a multicenter prospective cohort, were analyzed. Subjects were classified into four groups based on smoking history and COPD status. Multiple linear regression analysis was performed to determine the association between baseline viscosity and lung function decline after adjusting for age, sex, smoking status, and COPD status.
resultsOf the 292 participants, 93 (31.8%) patients had COPD. Ever smokers with or without COPD were older than never smokers and predominantly male. Never smokers with COPD reported the highest scores for the Modified Medical Research Council Dyspnea Scale. Blood viscosity was significantly higher in ever smokers (with COPD: 9.0 ± 1.4; without COPD 9.2 ± 1.5) than in never smokers (with COPD: 8.7 ± 1.8; without COPD: 8.4 ± 1.5). Viscosity did not differ significantly with the presence of COPD within the same smoking category. Adjusted multiple linear regression revealed that baseline blood viscosity was not associated with 2-year declines in forced expiratory volume in 1 s (p = 0.557), forced vital capacity (p = 0.686), or diffusing capacity of the lung for carbon monoxide (p = 0.947).
conclusionBlood viscosity appeared to be more closely associated with smoking-related hemorheological changes than with COPD. Its potential as a predictive biomarker for lung function decline appears to be limited, necessitating further long-term investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.